Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Akebia
9987 Carver Road, Suite 420
Cincinnati, OH 45242
Phone: 513-985-1920
www.akebia.com

Akebia Therapeutics is a discovery and development company focused on the treatment of chronic anemia. Akebia's lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in Phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimulate endogenous EPO production.

Key Contact
Name
Joseph H. Gardner, PhD
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/09/12 $4,100,000 AgeChem Venture Fund
Triathlon Medical Ventures
Venture Investors
undisclosed


Featured Reading